Order Article Reprints

Zehrung D, Innis BL, Suwantika AA, Ameri M, Biellik R, Birchall JC, Cravioto A, Jarrahian C, Fairlie L, Goodson JL, et al. Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations. Vaccines. 2024; 12(11):1258. https://doi.org/10.3390/vaccines12111258

Zehrung, Darin, Bruce L. Innis, Auliya A. Suwantika, Mahmoud Ameri, Robin Biellik, James C. Birchall, Alejandro Cravioto, Courtney Jarrahian, Lee Fairlie, James L. Goodson, and et al. 2024. "Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations" Vaccines 12, no. 11: 1258. https://doi.org/10.3390/vaccines12111258

Zehrung, D., Innis, B. L., Suwantika, A. A., Ameri, M., Biellik, R., Birchall, J. C., Cravioto, A., Jarrahian, C., Fairlie, L., Goodson, J. L., Kochhar, S., Kretsinger, K., Morgan, C., Mvundura, M., Rathi, N., Clarke, E., Mistilis, J. J., Uwamwezi, M.-C., Giersing, B., & Hasso-Agopsowicz, M. (2024). Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations. Vaccines, 12(11), 1258. https://doi.org/10.3390/vaccines12111258